Parkinson’s disease and Amyotrophic Lateral Sclerosis are the newest frontiers for open science drug discovery, a global movement led by academic scientists that puts knowledge sharing and medication affordability ahead of patents and profits.
Parkinson’s disease and Amyotrophic Lateral Sclerosis are the newest frontiers for open science drug discovery, a global movement led by academic scientists that puts knowledge sharing and medication affordability ahead of patents and profits.